Browsing: Chemoimmunotherapy

The discussion moves to real-world evidence and meta-analysis. The faculty first review a meta-analysis that pooled randomized trials with retrospective…

The panel reviews the KEYNOTE-966 long-term follow-up data. With long-term follow-up, the addition of pembrolizumab to gemcitabine and cisplatin maintained…

Burtness, Harrington B, Greil KJ, Soulières R, Tahara D, de Castro M, et al. Pembrolizumab alone or with chemotherapy versus…

Neoadjuvant chemoimmunotherapy (NACI) was associated with substantially higher rates of pathologic complete response (pCR) and major pathologic response (MPR) compared…

The faculty open the Between the Lines discussion by framing why advanced biliary tract cancer (BTC) remains a difficult-to-treat malignancy…

PatientsFrom February 20, 2021, to July 8, 2024, 358 patients were screened for eligibility (detailed reasons for screening failure are…

At the European Hematology Association (EHA) 2026 Congress, Christopher P. Fox, MBChB, PhD, FRCP, FRCPath, of Nottingham University Hospitals NHS…